- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04405648
Computer Vision Syndrome Prevalence Among University Students
December 21, 2022 updated by: Prof. Mohammed Iqbal, Sohag University
Prevalence and Severity of Computer Vision Syndrome Among Medical Students
CVS-F3 questionnaire will be used as an instrument to survey CVS prevalence and severity among medical students
Study Overview
Detailed Description
CVS-F3 is a valid questionnaire that includes 26 questions to be responded by the medical students to detect CVS complains and possible complications.
The questionnaire includes questions regarding potential ocular, extra-ocular, musclo-skeletal and neuro-psychatric complains caused by CVS.
Complete statistical analysis of the survey data will be done using univariate and multivariate logistic and linear regression analysis.
Study Type
Observational
Enrollment (Actual)
49
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Sohag, Egypt, 82425
- Faculty of medicine
-
Sohag, Egypt, 82425
- Sohag Faculty of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
medical students who are using screens in their medical studies or personal lives and how these screens affect their medical studies and the effect of mandated medical computer use if present on their screen-behaviour and associated risk factor
Description
Inclusion Criteria:
- university students
- studying medicine
Exclusion Criteria:
- ocular surgery
- amblyopia
- anisometropia
- strabismus
- DM
- hypertension
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prevalence of CVS
Time Frame: 1 month
|
will be reorted in form of percentage (%) of students with CVS
|
1 month
|
Visual acuity
Time Frame: 1 month
|
measurement of visual acuity using distance visual charts in logMAR measurements
|
1 month
|
Refraction
Time Frame: 1 month
|
measurement of refractive power in diopters
|
1 month
|
Schirmer test
Time Frame: 1 month
|
measurement of tear volume production with Schirmer test in mm unit measurements
|
1 month
|
Tear Break Up Time (TBUT)
Time Frame: 1 month
|
measurement of tear film stability with TBUT in seconds time unit measurements
|
1 month
|
mfERG examinations
Time Frame: 6 months
|
mfERG will be performed for the students to document the effect of CVS on retina
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Mohammed Iqbal, Sohag University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 28, 2020
Primary Completion (Actual)
October 20, 2020
Study Completion (Actual)
December 31, 2020
Study Registration Dates
First Submitted
May 24, 2020
First Submitted That Met QC Criteria
May 24, 2020
First Posted (Actual)
May 28, 2020
Study Record Updates
Last Update Posted (Estimate)
December 22, 2022
Last Update Submitted That Met QC Criteria
December 21, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 4-8/1/2018
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Computer Vision Syndrome
-
The Institute of Optometry, LondonUniversity of AlicanteCompleted
-
Sohag UniversityRecruiting
-
University of Central LancashireRecruiting
-
Sohag UniversityCompletedComputer Vision SyndromeEgypt
-
IRCCS Policlinico S. MatteoCompletedComputer Vision Syndrome | Video Display Terminal Workers
-
Sohag UniversityCompleted
-
Neurolens Inc.TerminatedComputer Vision Syndrome | Convergence Insufficiency | Binocular Vision DisorderUnited States
-
Aston UniversityNot yet recruitingDry Eye Syndromes | Computer Vision Syndrome
-
Neurolens Inc.CompletedHeadache | Computer Vision Syndrome | Convergence Insufficiency | Binocular Vision DisorderUnited States
Clinical Trials on CVS GROUP
-
Sohag UniversityCompletedComputer Vision SyndromeEgypt
-
Centre for Addiction and Mental HealthCompletedHealthy | SchizophreniaCanada
-
Abramson Cancer Center at Penn MedicineNational Cancer Institute (NCI); New York University; Stanford UniversityRecruitingSmoking | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
GlaxoSmithKlineCompletedInfections, PapillomavirusGermany, Poland
-
Wake Forest University Health SciencesWithdrawnSubstance Use DisordersUnited States
-
Alcon ResearchCompleted
-
University of California, BerkeleyAlcon ResearchCompleted
-
University of BonnUniversity of HohenheimCompleted